Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade

With the growing number of patients with inflammatory bowel disease (IBD) and hospitalization cases, the overall medical care cost elevates significantly in consequence. A total of 2458 hospitalizations, involving 1401 patients with IBD, were included from two large medical centers. Hospitalization...

Full description

Saved in:
Bibliographic Details
Main Authors: Junjie Xu, Minyue Tang, Jun Shen
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2013/267630
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554436564615168
author Junjie Xu
Minyue Tang
Jun Shen
author_facet Junjie Xu
Minyue Tang
Jun Shen
author_sort Junjie Xu
collection DOAJ
description With the growing number of patients with inflammatory bowel disease (IBD) and hospitalization cases, the overall medical care cost elevates significantly in consequence. A total of 2458 hospitalizations, involving 1401 patients with IBD, were included from two large medical centers. Hospitalization costs and factors impacting cost changes were determined. Patients with IBD and frequency of hospitalizations increased significantly from 2003 to 2011 (P<0.001). The annual hospitalization cost per patient, cost per hospitalization, and daily cost during hospitalization increased significantly in the past decade (all P<0.001). However, length of stay decreased significantly (P<0.001). Infliximab was the most significant factor associated with higher hospitalization cost (OR = 44380.09, P<0.001). Length of stay (OR = 1.29, P<0.001), no medical insurance (OR = 1.31, P=0.017), CD (OR = 3.55, P<0.001), inflammatory bowel disease unclassified (IBDU) (OR = 4.30, P<0.0001), poor prognosis (OR = 6.78, P<0.001), surgery (OR = 3.16, P<0.001), and endoscopy (OR = 2.44, P<0.001) were found to be predictors of higher hospitalization costs. Patients with IBD and frequency of hospitalizations increased over the past decade. CD patients displayed a special one peak for age at diagnosis, which was different from UC patients. The increased hospitalization costs of IBD patients may be associated with infliximab, length of stay, medical insurance, subtypes of IBD, prognosis, surgery, and endoscopy.
format Article
id doaj-art-93523fb7372e4991a6ccc6b468065fe2
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-93523fb7372e4991a6ccc6b468065fe22025-02-03T05:51:29ZengWileyGastroenterology Research and Practice1687-61211687-630X2013-01-01201310.1155/2013/267630267630Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past DecadeJunjie Xu0Minyue Tang1Jun Shen2Department of Medicine, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, 160 Pu Jian Avenue, Shanghai 200127, ChinaDepartment of Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, 197 Ruijiner Road, Shanghai 200025, ChinaDepartment of Gastroenterology, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai Institute of Digestive Disease, Shanghai Inflammatory Bowel Disease Research Center, 160 Pu Jian Avenue, Shanghai 200127, ChinaWith the growing number of patients with inflammatory bowel disease (IBD) and hospitalization cases, the overall medical care cost elevates significantly in consequence. A total of 2458 hospitalizations, involving 1401 patients with IBD, were included from two large medical centers. Hospitalization costs and factors impacting cost changes were determined. Patients with IBD and frequency of hospitalizations increased significantly from 2003 to 2011 (P<0.001). The annual hospitalization cost per patient, cost per hospitalization, and daily cost during hospitalization increased significantly in the past decade (all P<0.001). However, length of stay decreased significantly (P<0.001). Infliximab was the most significant factor associated with higher hospitalization cost (OR = 44380.09, P<0.001). Length of stay (OR = 1.29, P<0.001), no medical insurance (OR = 1.31, P=0.017), CD (OR = 3.55, P<0.001), inflammatory bowel disease unclassified (IBDU) (OR = 4.30, P<0.0001), poor prognosis (OR = 6.78, P<0.001), surgery (OR = 3.16, P<0.001), and endoscopy (OR = 2.44, P<0.001) were found to be predictors of higher hospitalization costs. Patients with IBD and frequency of hospitalizations increased over the past decade. CD patients displayed a special one peak for age at diagnosis, which was different from UC patients. The increased hospitalization costs of IBD patients may be associated with infliximab, length of stay, medical insurance, subtypes of IBD, prognosis, surgery, and endoscopy.http://dx.doi.org/10.1155/2013/267630
spellingShingle Junjie Xu
Minyue Tang
Jun Shen
Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade
Gastroenterology Research and Practice
title Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade
title_full Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade
title_fullStr Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade
title_full_unstemmed Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade
title_short Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade
title_sort trends and factors affecting hospitalization costs in patients with inflammatory bowel disease a two center study over the past decade
url http://dx.doi.org/10.1155/2013/267630
work_keys_str_mv AT junjiexu trendsandfactorsaffectinghospitalizationcostsinpatientswithinflammatoryboweldiseaseatwocenterstudyoverthepastdecade
AT minyuetang trendsandfactorsaffectinghospitalizationcostsinpatientswithinflammatoryboweldiseaseatwocenterstudyoverthepastdecade
AT junshen trendsandfactorsaffectinghospitalizationcostsinpatientswithinflammatoryboweldiseaseatwocenterstudyoverthepastdecade